Oliver Schnell - Concepedia

Author

Oliver Schnell

Also Known As

Daniel Delev, Joerg Christian Tonn, O Schnell, O. Schnell, Oliver Schnell, Schnell, O., Schnell, Oliver, Tonn, Joerg, Tonn, Joerg C

346

Publications

11.4K

Citations

H-Index

130

Concepts

All Affiliations

University of Freiburg University Medical Center Freiburg Ludwig-Maximilians-Universität München German Cancer Research Center Heidelberg University

About

Oliver Schnell is an author at University of Freiburg specializing in medicine, neuro-oncology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	42	5.2K
2	Health Sciences	13	14	1.3K
3	Engineering	7	7	180
4	Social Sciences	3	3	496
5	Biology	1	1	53

Oliver Schnell

108

Publications

10.8K

Citations

H-Index

Page 1

	Year	Citations
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial Michael Weller, Nicholas Butowski, David Tran, The Lancet Oncology Egfrviii-expressing GlioblastomaNeuro-oncologyAct IvGliomaInternational Phase 3	2017	1.1K
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial Roger Stupp, Monika E. Hegi, Thierry Gorlia, The Lancet Oncology Neuro-oncologyGliomaMedicineStandard TreatmentPathology	2014	1K
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma Vidhya M. Ravi, Paulina Will, Jan Kueckelhaus, Cancer Cell	2022	567
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack, The Lancet Hematological MalignancyNeuro-oncologyTreatment StrategiesMedicineStandard Temozolomide Therapy	2019	556
Mapping microglia states in the human brain through the integration of high-dimensional techniques Roman Sankowski, Chotima Böttcher, Takahiro Masuda, Nature Neuroscience Neuroimaging BiomarkersHigh-dimensional TechniquesCellular NeuroscienceComputational NeuroscienceMedicine	2019	448
A vaccine targeting mutant IDH1 in newly diagnosed glioma Michael Platten, Lukas Bunse, Antje Wick, Nature	2021	400
Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma Dieter Henrik Heiland, Vidhya M. Ravi, Simon P. Behringer, Nature Communications	2019	386
Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in Man Ambros J. Beer, Roland Haubner, Mario Sarbia, Clinical Cancer Research	2006	329
<i>MGMT</i> Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial Michael Weller, Ghazaleh Tabatabai, Bärbel Kästner, Clinical Cancer Research	2015	311
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10 Vidhya M. Ravi, Nicolas Neidert, Paulina Will, Nature Communications	2022	306

Page 1